Replies to post #41505 on OncoSec Medical Inc (ONCSQ)

[dr_lowenstein]

No market cap is what is important

[DDJ]

Looks like Idera will possibly be doing a R/S in 2018. ONCS data looks more promising IMO (we will hear more on Saturday) Why did Idera do an offering well below the current share price? Seems just as volatile as ONCS. Both therapies seem to be targeting patients that won't respond to an anti-PD-1 alone.